Psoriatic Arthritis

The FDA has approved a supplemental biologics licensing application from Bristol Myers Squibb expanding the indication of abatacept to include children aged 2 years and older with psoriatic arthritis, according to a company press release.

Patients across health care specialties have in recent years come to expect some form of individually tailored care — or precision medicine — as part of their disease management.

The FDA has denied a biologics license application from Alvotech for its biosimilar to ustekinumab, citing “certain deficiencies” at the company’s facility in Reykjavik, Iceland, according to the manufacturer.

The FDA has approved an intravenous formulation of Cosentyx for use in patients with psoriatic arthritis, ankylosing spondylitis and nonradiographic axial spondyloarthritis, according to a press release from Novartis.

SAN DIEGO — Patient age and disease-related factors may be driving safety signals in medications used to treat rheumatoid arthritis and psoriatic disease, according to a speaker at the 2023 Congress of Clinical Rheumatology West.

SAN DIEGO — The varying domains of psoriatic disease create challenges in defining treatment algorithms, according to a speaker at the 2023 Congress of Clinical Rheumatology West.

Patient-reported outcomes in individuals with psoriatic arthritis receiving either ustekinumab or TNF inhibitors were “generally comparable” after 3 years of follow-up, according to data published in Arthritis Research & Therapy.

Age, disease duration and sex are factors that may predict how likely a patient with psoriatic arthritis may be to enter remission following therapy with a TNF inhibitor, according to data published in Rheumatology.

Among patients with psoriasis, arthralgia should be considered a risk factor predicting progression to psoriatic arthritis, according to new EULAR points to consider for suspicious features in early PsA development.

Patients with axial spondyloarthritis and psoriatic arthritis routinely “bounce” from one provider to the next for years before finally receiving the correct diagnosis in a rheumatology clinic, according to experts.